Dundee Corporation Acquires Further Interest in Diagnos Inc.

TORONTO, ONTARIO--(Marketwire - July 11, 2012) - In accordance with regulatory requirements, Dundee Corporation (TSX:DC.A) ("Dundee") announces that it has acquired 1,416,500 common shares of Diagnos Inc. ("Diagnos") through the facilities of the TSX Venture Exchange. Dundee now owns 5,654,431 common shares and 2,068,966 warrants, representing an approximate 8.86% interest in Diagnos on an undiluted basis or 11.72% assuming the exercise of all warrants.

The position in Diagnos was acquired for investment purposes and may be increased or decreased in the future as considered appropriate in light of investment criteria, market conditions and other factors and in accordance with the provisions of applicable securities legislation.